Product Description
The global left atrial appendage closure device market was valued at $2.3 billion in 2025. This is expected to increase over the forecast period at a CAGR of 10.5% to reach $4.6 billion by 2032.
The full report suite on the global market for left atrial appendage (LAA) closure device includes endocardial and epicardial devices.
The report includes data for 65+ countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Left Atrial Appendage Closure Device Market Trends

The global left atrial appendage closure device market remains concentrated among a limited number of manufacturers; however, interest in this space has increased in recent years. Additional companies are entering or expanding their presence in the market, resulting in a more competitive landscape. As competition intensifies, pricing pressure is expected to increase, moderating overall market value growth over the forecast period.
Global Left Atrial Appendage Closure Device Market Share Insights

- Boston Scientific was the leader of the global left atrial appendage closure device market in 2025. Boston Scientific offers its WATCHMAN™ LAA closure devices as an endocardial option. While Boston Scientific accounts for the majority of the market, once other endocardial devices start getting regulatory approval, the company should lose some share to new entrants.
- Abbott was the second-leading competitor in the global left atrial appendage closure device market in 2025. Abbott offers its Amplatzer™ Amulet™ LAA Occluder as an endocardial LAA device. It is expected that Abbott will grow its market share in the coming years due to the established use of the line.
- AtriCure was the third-leading competitor in the global left atrial appendage closure device market in 2025. AtriCure offers the AtriClip® product line as its epicardial option. The AtriClip® has multiple devices within it. Given the product line is expansive, it is expected that the company will maintain its market share over the coming years.
Global Left Atrial Appendage Closure Device Market Segmentation Summary
- Endocardial Left Atrial Appendage Device Market
- Epicardial Clip Left Atrial Appendage Device Market
- Epicardial Suture Left Atrial Appendage Device Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis for Top Competitors, Mergers & Acquisitions, Emerging Markets & Technologies, Key Analysis Updates. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.